Re: RVX Status
|
6
|
Resverlogix Corp.
|
Nov 28, 2020 01:23AM
|
Re: PAH Plans get a write up in Pulmonary Hypertension News
|
6
|
Resverlogix Corp.
|
May 21, 2019 02:23PM
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
6
|
Resverlogix Corp.
|
Sep 19, 2020 07:47PM
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
6
|
Resverlogix Corp.
|
Aug 07, 2020 02:04AM
|
Re: The silence on....
|
6
|
Resverlogix Corp.
|
Nov 14, 2019 07:26PM
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
6
|
Resverlogix Corp.
|
Jan 13, 2021 01:20AM
|
Re: All quiet on the western front
|
6
|
Resverlogix Corp.
|
Jan 04, 2020 02:36AM
|
Re: We should get financials this week
|
6
|
Resverlogix Corp.
|
Mar 22, 2021 03:43PM
|
Defining Value
|
6
|
Resverlogix Corp.
|
Sep 30, 2019 09:35AM
|
Re: 47 Taken out by Gilead for $4.9 billion
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 07:40AM
|
Re: 47 Taken out by Gilead for $4.9 billion
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 07:55AM
|
Re: Covid and BETonMACE, etc. Rambling.
|
6
|
Resverlogix Corp.
|
Apr 25, 2021 10:42AM
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 01:21PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 15, 2021 03:32PM
|
Re: Questions about units
|
6
|
Resverlogix Corp.
|
May 18, 2019 06:30AM
|
Re: Deal or no Deal?
|
6
|
Resverlogix Corp.
|
Jul 23, 2020 08:44AM
|
Re: I asked IR...
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 05:14PM
|
Re: Apabetalone......a Calculated Risk
|
6
|
Resverlogix Corp.
|
Apr 09, 2019 08:10AM
|
Re: Article on NASH Liver Disease
|
6
|
Resverlogix Corp.
|
Aug 18, 2019 02:27AM
|
Re: Patience
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 08:28AM
|